JJL, v. G., B, E., SG, E., AH, B., F, B., SL, G., . . . CP, S. (2026). 18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial. JAMA oncology, 12(6), 611. https://doi.org/10.1001/jamaoncol.2026.0767
Chicago Style (17th ed.) CitationJJL, van Geel, et al. "18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial." JAMA Oncology 12, no. 6 (2026): 611. https://doi.org/10.1001/jamaoncol.2026.0767.
MLA (9th ed.) CitationJJL, van Geel, et al. "18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial." JAMA Oncology, vol. 12, no. 6, 2026, p. 611, https://doi.org/10.1001/jamaoncol.2026.0767.